Anal Fistula Drugs Market

Medications for anal fissures such as topical nitrates, calcium channel blockers, and onabotulinumtoxinA injections are considered first-line therapy. These medications reduce anal sphincter tone, which, in turn, increases anodermal blood flow. Antibiotics may be necessary for the treatment of anal fistulas
Anal Fistula Drugs Market contains market size and forecasts of Anal Fistula Drugs in Global, including the following market information:
Global Anal Fistula Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anal Fistula Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Laxatives Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anal Fistula Drugs include Pfizer, AbbVie, Bayer, Novartis, Mylan, Teva Pharmaceuticals, Bausch Health, Takeda and Kyowa Kirin (ProStrakan), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anal Fistula Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anal Fistula Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anal Fistula Drugs Market Segment Percentages, by Type, 2021 (%)
Laxatives
Antibiotics
Topical Nitrates
Calcium Channel Blockers
OnabotulinumtoxinA Injections
Others
Global Anal Fistula Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anal Fistula Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Anal Fistula Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anal Fistula Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anal Fistula Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anal Fistula Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AbbVie
Bayer
Novartis
Mylan
Teva Pharmaceuticals
Bausch Health
Takeda
Kyowa Kirin (ProStrakan)
Boiron
Roche
Hikma Pharmaceuticals
TWi Pharmaceuticals
Sanofi
Sun Pharmaceutical
Bristol Myers
Akorn
Dr. Reddys
Lupin
Advanz Pharmaceutical
Aurobindo pharma
Baxter International